Login to Your Account

U.S. drugmakers might be on the losing end in trade war with China

By David Ho
Staff Writer

Wednesday, April 11, 2018

HONG KONG – The Trump administration has proposed placing a 25 percent tariff on more than 1,300 imported goods from China, such as biotech materials and medical devices, a move some say could eventually hurt U.S. drugmakers.

To continue reading subscribe now to BioWorld Asia (formerly International)

Learn More about BioWorld Asia (formerly International)

Already a subscriber? Sign In or Buy now to activate your subscription